Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
PTPRT Biologics Sequence Review Report 2026: Receptor-type tyrosine-protein phosphatase T Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of PTPRT protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
GPR171 Biologics Sequence Review Report 2026: G protein-coupled receptor 171 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR171 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
CLDN4 Biologics Sequence Review Report 2026: Claudin-4 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CLDN4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
IL18RAP Biologics Sequence Review Report 2026: Interleukin-18 receptor accessory protein Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of IL18RAP protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
TNFRSF11B Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 11B Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TNFRSF11B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
GPR31 Biologics Sequence Review Report 2026: 12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid receptor Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR31 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
TNFRSF10A Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 10A Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TNFRSF10A protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
TLR2 Biologics Sequence Review Report 2026: Toll-like receptor 2 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TLR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
TLR5 Biologics Sequence Review Report 2026: Toll-like receptor 5 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TLR5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ITGB1BP1 Biologics Sequence Review Report 2026: Integrin beta-1-binding protein 1 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of ITGB1BP1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
CXCL13 Biologics Sequence Review Report 2026: C-X-C motif chemokine 13 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CXCL13 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
FGF17 Biologics Sequence Review Report 2026: Fibroblast growth factor 17 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of FGF17 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.